Heres What Key Metrics Tell Us About DoubleVerify Q1 Earnings - Yahoo Finance UK
| 6539 Stock | TWD 66.60 0.20 0.30% |
Slightly above 62% of DV Biomed's investor base is looking to short. The analysis of current outlook of investing in DV Biomed Co suggests that many traders are alarmed regarding DV Biomed's prospects. DV Biomed's investing sentiment can be driven by a variety of factors including economic data, DV Biomed's earnings reports, geopolitical events, and overall market trends.
DV Biomed stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of 6539 daily returns and investor perception about the current price of DV Biomed Co as well as its diversification or hedging effects on your existing portfolios.
6539 |
Heres What Key Metrics Tell Us About DoubleVerify Q1 Earnings Yahoo Finance UK
Read at news.google.com
 |
DV Biomed Fundamental Analysis
We analyze DV Biomed's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DV Biomed using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DV Biomed based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
DV Biomed is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
DV Biomed Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with DV Biomed stock to make a market-neutral strategy. Peer analysis of DV Biomed could also be used in its relative valuation, which is a method of valuing DV Biomed by comparing valuation metrics with similar companies.
Peers
DV Biomed Related Equities
| 6209 | Kinko Optical | 1.43 | ||||
| 9945 | Ruentex Development | 1.34 | ||||
| 1796 | GeneFerm Biotechnology | 1.32 | ||||
| 6697 | Information Technology | 0.45 | ||||
| 9933 | CTCI Corp | 0.24 | ||||
| 9908 | Great Taipei | 0.33 | ||||
| 9921 | Giant Manufacturing | 1.32 | ||||
| 5534 | Chong Hong | 1.45 | ||||
| 6438 | Symtek Automation | 2.83 |
Additional Tools for 6539 Stock Analysis
When running DV Biomed's price analysis, check to measure DV Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DV Biomed is operating at the current time. Most of DV Biomed's value examination focuses on studying past and present price action to predict the probability of DV Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DV Biomed's price. Additionally, you may evaluate how the addition of DV Biomed to your portfolios can decrease your overall portfolio volatility.